Form 4: Arcus Biosciences CEO Terry Rosen Disposes of Shares to Cover Tax Obligations

Arcus Biosciences CEO Terry Rosen disposed of 12,670 shares of common stock on June 15, 2024, to cover tax withholding obligations related to the vesting and settlement of RSUs.

Summary

• On June 15, 2024, Terry Rosen, CEO of Arcus Biosciences, disposed of 12,670 shares of common stock.
• The transaction was executed to cover tax withholding obligations associated with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
• The shares were disposed of at a price of $16.97 per share.
• Following the transaction, Rosen directly owns 3,954,304 shares of Arcus Biosciences common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects a routine transaction to cover tax obligations, which is a normal part of executive compensation. It doesn't inherently indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are a routine part of insider trading activity and are closely monitored by investors for insights into management's perspective on the company's stock. Disposals to cover tax obligations are common and don't necessarily indicate a negative outlook.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine disposal to cover tax obligations.

Key Dates